This articles by Pat Anson of Pain News Networks sites the first opinion piece from a practicing attorney that I have read since I started covering the opioid crisis and it is long overdue. Counselor Barnes is a managing partner of DCBA Law & Policy, a law firm that advises healthcare providers.
July 11, 2019 saw U.S. Senators Joe Manchin (D-WV) and Mike Braun (R-IN), introduced the FDA Opioid Labeling Accuracy Act, which would prohibit the Food and Drug Administration (FDA) from allowing opioids to be labeled for intended use of “around-the clock, long-term opioid treatment” until a study can be completed on the long-term usage of opioids.
Josh Bloom rarely disappoints and in this article about UK opioid hysteria, he calls out the fake claims as he sees them.
Conversations and articles have been popping up around the internet about Facebook’s censorship of pages, posts or comments which may be related to pro-opioid points of view.
Drug companies shipped billions of painkillers to communities across America without proper oversight between 2006 and 2012, according to newly released data from the Drug Enforcement Administration (DEA), highlighting the pharmaceutical industry’s role in the opioid epidemic as it faces a possible legal reckoning similar to that which befell the tobacco companies in the 1990s.
The data shows that companies distributed 8.4 billion hydrocodone and oxycodone pills to commercial pharmacies in 2006 and 12.6 billion in 2012. That’s an increase of over 50%.
So what are our healthcare professional and law enforcement agencies failing to recognize in their efforts to balance combating opioid abuse while humanely and responsibly managing chronic pain conditions for the public?
While the CDC breaks out data points for causes unrelated to mental health issues, the one category missing in its data collection efforts, and one for which they have abundant data, are the suicides related to forced tapering or termination of opioids in patients with legitimate medical needs.